<html>
<head>
<title>Section 318-B:42 Commission Established;  Membership;  Duties.</title>
<!-- Hide metadata
<titlename>TITLE XXX OCCUPATIONS AND PROFESSIONS</titlename>
<chapter>CHAPTER 318-B CONTROLLED DRUG ACT</chapter>
<sectiontitle>Section 318-B:42 Commission Established;  Membership;  Duties.</sectiontitle>
-->
</head>
<body>
<center><h1>TITLE XXX<br>OCCUPATIONS AND PROFESSIONS</h1></center>
<center><h2>CHAPTER 318-B<br>CONTROLLED DRUG ACT</h2></center>
<center><h2>Controlled Drug Prescription Health and Safety Program</h2></center>
<center><h3>Section 318-B:42</h3></center>
<br><center>[RSA 318-B:42 repealed by 2016, 309:3, effective November 1, 2016.]</center>
&nbsp;&nbsp;&nbsp;<b> 318-B:42 Commission Established;  Membership;  Duties. &#150;</b>
<codesect>
<br>
&nbsp&nbsp&nbsp
I. There is established a commission to study requiring controlled drugs and controlled drug analogs to be provided in abuse-deterrent formulation.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(a) The members of the commission shall be as follows:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(1) One member of the senate, appointed by the president of the senate.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(2) One member of the house of representatives, appointed by the speaker of the house of representatives.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(3) The commissioner of the department of health and human services, or designee.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(4) A pharmacist, appointed by the board.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(5) Three licensed physicians, one of whom shall specialize in pain medicine, one of whom shall specialize in addiction medicine, and one of whom practices in the field of primary care medicine, appointed by the board of medicine.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(6) An APRN, appointed by the New Hampshire board of nursing.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(7) A representative of an abuse-deterrent drug manufacturer, appointed by the governor.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(8) A representative of an insurance company, appointed by the governor.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(9) The executive director of New Futures, or designee.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.
<br>
&nbsp&nbsp&nbsp
II. (a) The commission shall study requiring controlled drugs and controlled drug analogs to be provided in abuse-deterrent formulation when available.  The commission's study shall include, but not be limited to:
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(1) The cost effectiveness of requiring such drugs to be provided in abuse-deterrent formulation.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(2) Whether the abuse-deterrent formulation of the drugs work.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(3) Whether the abuse-deterrent formulation of such drugs are readily available.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(4) The effect requiring such drugs to be provided in abuse-deterrent formulation will have on insurance premiums.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(5) A review of current insurance carrier coverage and prior authorization practices.
<br>
&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp
(b) The commission shall solicit information from any person or entity the commission deems relevant to its study.
<br>
&nbsp&nbsp&nbsp
III. The members of the commission shall elect a chairperson from among the members.  The first meeting of the commission shall be called by the senate member.  The first meeting of the commission shall be held within 45 days of the effective date of this section.  Six members of the commission shall constitute a quorum.
<br>
&nbsp&nbsp&nbsp
IV. The commission shall make a report on or before November 1, 2016 indicating its findings and any recommendations for proposed legislation to the president of the senate, the speaker of the house of representatives, the senate clerk, the house clerk, the governor, and the state library.
</codesect>
<sourcenote>
<p><b>Source.</b>  2016, 309:2, eff. June 21, 2016.</p>
</sourcenote>
</body>
</html>
